Nestlé has agreed to acquire core vitamin and supplement brands of The Bountiful Company from investment firm KKR for $5.75 billion, as it looks to expand its health and nutrition portfolio.
The Bountiful Company is a US manufacturer and seller of vitamins, minerals, herbal and other speciality supplements and active nutrition products.
The deal includes brands such as Nature’s Bounty, Solgar, Osteo Bi-Flex and Puritan’s Pride, as well as the company’s US private label business. In the last 12 months, these brands recorded net sales of $1.87 billion.
Upon completion, the brands will be integrated into Nestlé Health Science – joining its existing brands including Garden of Life, Vital Proteins, Persona Nutrition, Pure Encapsulations and Genestra.
Meanwhile, The Bountiful Company’s sports and active nutrition brands – Pure Protein, Body Fortress and Met-Rx – as well as its personal care brand Dr.Organic and Canadian over-the-counter (OTC) business are not included in the sale.
The acquisition marks another move by Nestlé to grow its health portfolio – which helped the company beat its full-year expectations – and become a leader in vitamins, minerals and nutritional supplements. Unilever is also building its consumer health portfolio and recently agreed to acquire US supplements brand Onnit.
“Vitamins and supplements are a key part of our business and have contributed to strong growth acceleration,” said Nestlé Health Science CEO, Greg Behar.
“This acquisition complements our existing health and nutrition portfolio in terms of brands and channels. It will establish Nestlé Health Science as the industry leader in mass retail, specialty retail, ecommerce and direct-to-consumer in the US, while offering significant opportunities for geographic growth.”
KKR acquired a majority interest in The Bountiful Company from The Carlyle Group back in 2017, with the latter retaining a minority stake in the company and therefore also involved in this agreement.
“Since KKR’s investment, The Bountiful Company has transformed into a leading, fast growth, pure-play nutrition platform through significant investments in talent, brand building, R&D, ecommerce, and manufacturing capabilities,” said Felix Gernburd, managing director at KKR.
Paul Sturman, president and CEO of The Bountiful Company, said: “Today’s announcement from Nestlé Health Science recognises the transformation of The Bountiful Company over the past three+ years, as well as the collective value and capability of the organisation.
“As a leader in global nutrition, we take seriously our responsibility and role in consumers’ health and wellness. We’re incredibly proud of the trusted brands we’ve built and are confident that they will be strong assets for Nestlé.”
The transaction is expected to close in the second half of 2021, subject to regulatory approvals and customary closing conditions.
By Emma Upshall
Paine Schwartz Partners has closed on a Paine Schwartz Food Chain Fund VI, L.P. at $1.7 billion. The fund is aimed at investing in the food and agribusiness value chain. The company has invested about 40% of Fund VI in AgroFresh Solutions, Costa Group, Elemental Enzymes, HGS BioScience and Monterey Mushrooms.
After 26 years in Geneva, Switzerland, the decision to move has been made after visitor and exhibitor feedback, as well as growth plans for the Vitafoods brand. Vitafoods Europe 2025 will be held on 20-22 May 2025 at Fira Barcelona, with more details to be announced next year.
The traditional symbol of family reunion and cultural pastry of Asia is undergoing a reinvention. With the majority of young consumers in Asia expressing an increasing interest in healthier options, a growing market for mooncakes tailored to dietary preferences and restrictions is opening up across the globe.